UB Paderborn / Katalog / Suche / in CDI

IL-7 surface-engineered lentiviral vectors promote survival and efficient gene transfer in resting primary T lymphocytes

Blood, 2003-03, Vol.101 (6), p.2167-2174

2003

Link zum Volltext

Verfügbarkeit prüfen

TET2 as a tumor suppressor and therapeutic target in T-cell acute lymphoblastic leukemia

Proceedings of the National Academy of Sciences - PNAS, 2021-08, Vol.118 (34), p.1

2021

Link zum Volltext

Verfügbarkeit prüfen

RNA-sequencing and mass-spectrometry proteomic time-series analysis of T-cell differentiation identified multiple splice variants models that predicted validated protein biomarkers in inflammatory diseases

Frontiers in molecular biosciences, 2022-08, Vol.9, p.916128-916128

2022

Link zum Volltext

Verfügbarkeit prüfen

Lentivirus-Mediated RNA Interference of DC-SIGN Expression Inhibits Human Immunodeficiency Virus Transmission from Dendritic Cells to T Cells

Journal of Virology, 2004-10, Vol.78 (20), p.10848-10855

2004

Link zum Volltext

Verfügbarkeit prüfen

Modalities of Interleukin-7-Induced Human Immunodeficiency Virus Permissiveness in Quiescent T Lymphocytes

Journal of Virology, 2002-09, Vol.76 (18), p.9103-9111

2002

Link zum Volltext

Verfügbarkeit prüfen

Intracellular calcium: lack of effect on ovine red cells

Proceedings of the Society for Experimental Biology and Medicine, 1978-03, Vol.157 (3), p.506-510

1978

Link zum Volltext

Verfügbarkeit prüfen

Tentative use of protective prosthesis in surgery of the maxilla

Svenska lakartidningen, 1957-03, Vol.54 (12), p.902

1957

Link zum Volltext

Verfügbarkeit prüfen

A case report: carcinoma of oral mucosa?

Tandläkartidningen, 1986-05, Vol.78 (10), p.566

1986

Link zum Volltext

Verfügbarkeit prüfen

Drug survival of anti‐TNF agents compared with vedolizumab as a second‐line biological treatment in inflammatory bowel disease: results from nationwide Swedish registers

Alimentary pharmacology & therapeutics, 2021-02, Vol.53 (4), p.471-483

2021

Link zum Volltext

Verfügbarkeit prüfen

Editorial: anti‐TNF agents against vedolizumab as a second‐line treatment? Not surprising tie game—authors’ reply

Alimentary pharmacology & therapeutics, 2021-03, Vol.53 (5), p.642-643

2021

Link zum Volltext

Verfügbarkeit prüfen

Letter: vedolizumab or a second anti‐TNF—no difference in efficacy for primary biologic failures with IBD. Authors' reply

Alimentary pharmacology & therapeutics, 2021-05, Vol.53 (9), p.1046-1047

2021

Link zum Volltext

Verfügbarkeit prüfen

Real-world effectiveness of vedolizumab in inflammatory bowel disease: week 52 results from the Swedish prospective multicentre SVEAH study

Therapeutic advances in gastroenterology, 2021, Vol.14, p.17562848211023386-17562848211023386

2021

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness of anti-TNF vs. vedolizumab as a second biologic in IBD: results from national Swedish registers

JOURNAL OF CROHNS & COLITIS, 2020, Vol.14 (Suppl. 1), p.S317

2020

Link zum Volltext

Verfügbarkeit prüfen

Clinical effectiveness of golimumab in Crohn's disease: an observational study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG)

Scandinavian journal of gastroenterology, 2018-11, Vol.53 (10-11), p.1257-1263

2018

Link zum Volltext

Verfügbarkeit prüfen

Pros and cons of vertical integration between clinical medicine and basic science within a problem-based undergraduate medical curriculum: examples and experiences from Linköping, Sweden

Medical teacher, 2002-05, Vol.24 (3), p.280-285

2002

Link zum Volltext

Verfügbarkeit prüfen

P327 Effectiveness of anti-TNF vs. vedolizumab as a second biologic in IBD: results from national Swedish registers

Journal of Crohn's and colitis, 2020-01, Vol.14 (Supplement_1), p.S317-S317

2020

Link zum Volltext

Verfügbarkeit prüfen

Seismicity of mid-oceanic ridges and its geodynamic implications: a review

Earth-science reviews, 2002-07, Vol.58 (1), p.143-161

2002

Link zum Volltext

Verfügbarkeit prüfen

Clinical effectiveness of vedolizumab: Interim analysis of the Swedish observational study on vedolizumab assessing effectiveness and healthcare resource utilisation in patients with ulcerative colitis (SVEAH UC)

JOURNAL OF CROHNS & COLITIS, 2018, Vol.12 (Suppl. 1), p.S382

2018

Link zum Volltext

Verfügbarkeit prüfen

Clinical effectiveness of vedolizumab: Interim analysis of the Swedish observational study on vedolizumab assessing effectiveness and healthcare resource utilisation in patients with Crohn's disease (SVEAH CD)

JOURNAL OF CROHNS & COLITIS, 2018, Vol.12 (Suppl. 1), p.S494

2018

Link zum Volltext

Verfügbarkeit prüfen

A Swedish observational study (SVEAH) on vedolizumab assessing effectiveness and healthcare resource utilization in patients with inflammatory bowel disease

JOURNAL OF CROHNS & COLITIS, 2017, Vol.11 (Suppl. 1), p.S262

2017

Link zum Volltext

Verfügbarkeit prüfen

Real-world effectiveness of vedolizumab in ulcerative colitis: Week 52 results from the Swedish multi-centre, prospective, observational SVEAH UC study

Journal of Crohn's and colitis, 2020, Vol.14 (Suppl. 1), p.S576

2020

Link zum Volltext

Verfügbarkeit prüfen

Attitudes among students and teachers on vertical integration between clinical medicine and basic science within a problem-based undergraduate medical curriculum

Medical teacher, 2002, Vol.24 (3), p.286-288

2002

Link zum Volltext

Verfügbarkeit prüfen

P547 Clinical effectiveness of vedolizumab: Interim analysis of the Swedish observational study on vedolizumab assessing effectiveness and healthcare resource utilisation in patients with ulcerative colitis (SVEAH UC)

Journal of Crohn's and colitis, 2018-01, Vol.12 (supplement_1), p.S382-S383

2018

Link zum Volltext

Verfügbarkeit prüfen

P758 Clinical effectiveness of vedolizumab: Interim analysis of the Swedish observational study on vedolizumab assessing effectiveness and healthcare resource utilisation in patients with Crohn’s disease (SVEAH CD)

Journal of Crohn's and colitis, 2018-01, Vol.12 (supplement_1), p.S494-S495

2018

Link zum Volltext

Verfügbarkeit prüfen

P364 A Swedish observational study (SVEAH) on vedolizumab assessing effectiveness and healthcare resource utilization in patients with inflammatory bowel disease

Journal of Crohn's and colitis, 2017-02, Vol.11 (suppl_1), p.S262-S263

2017

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

IL-7 surface-engineered lentiviral vectors promote survival and efficient gene transfer in resting primary T lymphocytes

TET2 as a tumor suppressor and therapeutic target in T-cell acute lymphoblastic leukemia

RNA-sequencing and mass-spectrometry proteomic time-series analysis of T-cell differentiation identified multiple splice variants models that predicted validated protein biomarkers in inflammatory diseases

Lentivirus-Mediated RNA Interference of DC-SIGN Expression Inhibits Human Immunodeficiency Virus Transmission from Dendritic Cells to T Cells

Modalities of Interleukin-7-Induced Human Immunodeficiency Virus Permissiveness in Quiescent T Lymphocytes

Intracellular calcium: lack of effect on ovine red cells

Tentative use of protective prosthesis in surgery of the maxilla

A case report: carcinoma of oral mucosa?

Drug survival of anti‐TNF agents compared with vedolizumab as a second‐line biological treatment in inflammatory bowel disease: results from nationwide Swedish registers

Editorial: anti‐TNF agents against vedolizumab as a second‐line treatment? Not surprising tie game—authors’ reply

Letter: vedolizumab or a second anti‐TNF—no difference in efficacy for primary biologic failures with IBD. Authors' reply

Real-world effectiveness of vedolizumab in inflammatory bowel disease: week 52 results from the Swedish prospective multicentre SVEAH study

Effectiveness of anti-TNF vs. vedolizumab as a second biologic in IBD: results from national Swedish registers

Clinical effectiveness of golimumab in Crohn's disease: an observational study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG)

Pros and cons of vertical integration between clinical medicine and basic science within a problem-based undergraduate medical curriculum: examples and experiences from Linköping, Sweden

P327 Effectiveness of anti-TNF vs. vedolizumab as a second biologic in IBD: results from national Swedish registers

Seismicity of mid-oceanic ridges and its geodynamic implications: a review

Clinical effectiveness of vedolizumab: Interim analysis of the Swedish observational study on vedolizumab assessing effectiveness and healthcare resource utilisation in patients with ulcerative colitis (SVEAH UC)

Clinical effectiveness of vedolizumab: Interim analysis of the Swedish observational study on vedolizumab assessing effectiveness and healthcare resource utilisation in patients with Crohn's disease (SVEAH CD)

A Swedish observational study (SVEAH) on vedolizumab assessing effectiveness and healthcare resource utilization in patients with inflammatory bowel disease

Real-world effectiveness of vedolizumab in ulcerative colitis: Week 52 results from the Swedish multi-centre, prospective, observational SVEAH UC study

Attitudes among students and teachers on vertical integration between clinical medicine and basic science within a problem-based undergraduate medical curriculum

P547 Clinical effectiveness of vedolizumab: Interim analysis of the Swedish observational study on vedolizumab assessing effectiveness and healthcare resource utilisation in patients with ulcerative colitis (SVEAH UC)

P758 Clinical effectiveness of vedolizumab: Interim analysis of the Swedish observational study on vedolizumab assessing effectiveness and healthcare resource utilisation in patients with Crohn’s disease (SVEAH CD)

P364 A Swedish observational study (SVEAH) on vedolizumab assessing effectiveness and healthcare resource utilization in patients with inflammatory bowel disease

Suchergebnisse filtern